抗发作药物的基本原理:从A到Z
Timothy E Welty1,2, Jeannine M Conway3, Jacquelyn Bainbridge4
1UnityPoint Health, Des Moines, Iowa.
许多抗发作药物 (ASM) 存在于,但由于可用性变化和精密医学的兴起,它们的选择具有挑战性. 本综述指导临床医生在和 status epilepticus 中最佳使用ASM.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自1857年化物引入以来,治疗已经发生了显著的进化.
- 许多抗发作药物 (ASM) 现在可用于和状态.
- 由于ASM的扩散,临床医生在选择和最佳利用方面面临挑战.
研究的目的:
- 为了提供对较旧和较新的抗发作药物的全面概述.
- 讨论精准医学在定制治疗中的作用.
- 审查当前对 status epilepticus 管理和全球 ASM 可访问性的理解.
主要方法:
- 关于抗发作药物的文献综述.
- 对精准医学在方面的进展进行分析.
- 对 status epilepticus 的治疗策略的检查.
- 评估全球抗发作药物的可用性.
主要成果:
- 有广泛的ASM选项可供选择,从传统到新型药物.
- 精准医学为治疗提供了有针对性的治疗的潜力.
- 有效管理状态需要仔细考虑可用的治疗方法.
- 在ASM访问全球差异影响治疗可访问性.
结论:
- 优化抗发作药物选择需要对药物特征和患者特定因素有充分的了解.
- 精准医学和最新的病状况指南对于推进病护理至关重要.
- 解决药物获取方面的全球不平等问题对于全面的管理至关重要.
更多相关视频
06:45Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
相关概念视频
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
